These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 24112036

  • 21. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells.
    Zhao X, Liu G, Shen H, Gao B, Li X, Fu J, Zhou J, Ji Q.
    Int J Mol Med; 2015 Mar; 35(3):684-92. PubMed ID: 25573030
    [Abstract] [Full Text] [Related]

  • 22. Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats.
    Luo X, Pan L, Nie A, Wang Q, Gu Y, Li F, Zhang H, Li W, Li X.
    J Diabetes; 2013 Dec; 5(4):421-8. PubMed ID: 23590680
    [Abstract] [Full Text] [Related]

  • 23. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.
    Wang XJ, Xu JX.
    Neurosci Res; 2005 Feb; 51(2):129-38. PubMed ID: 15681030
    [Abstract] [Full Text] [Related]

  • 24. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway.
    Kimura R, Okouchi M, Fujioka H, Ichiyanagi A, Ryuge F, Mizuno T, Imaeda K, Okayama N, Kamiya Y, Asai K, Joh T.
    Neuroscience; 2009 Sep 15; 162(4):1212-9. PubMed ID: 19463904
    [Abstract] [Full Text] [Related]

  • 25. Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.
    Popelová A, Kákonová A, Hrubá L, Kuneš J, Maletínská L, Železná B.
    Physiol Res; 2018 May 04; 67(2):339-346. PubMed ID: 29303606
    [Abstract] [Full Text] [Related]

  • 26. Liraglutide (Victoza) for type 2 diabetes.
    Med Lett Drugs Ther; 2010 Apr 05; 52(1335):25-7. PubMed ID: 20360660
    [Abstract] [Full Text] [Related]

  • 27. Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases.
    Hölscher C.
    Sheng Li Xue Bao; 2014 Oct 25; 66(5):497-510. PubMed ID: 25331995
    [Abstract] [Full Text] [Related]

  • 28. Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.
    Song J, Hou L, Ju C, Zhang J, Ge Y, Yue W.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):235-41. PubMed ID: 23376416
    [Abstract] [Full Text] [Related]

  • 29. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H, Hartmann B, Holst JJ, Viby NE, Hansen LS, Rosenkilde MM, Hare KJ, Poulsen SS.
    Regul Pept; 2012 Nov 10; 179(1-3):91-100. PubMed ID: 22989472
    [Abstract] [Full Text] [Related]

  • 30. Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation.
    Chang TJ, Tseng HC, Liu MW, Chang YC, Hsieh ML, Chuang LM.
    Sci Rep; 2016 Mar 21; 6():23403. PubMed ID: 26997114
    [Abstract] [Full Text] [Related]

  • 31. Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2.
    An WL, Pei JJ, Nishimura T, Winblad B, Cowburn RF.
    Brain Res Mol Brain Res; 2005 Apr 27; 135(1-2):40-7. PubMed ID: 15857667
    [Abstract] [Full Text] [Related]

  • 32. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line.
    Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB.
    Neuropharmacology; 2007 Nov 27; 53(6):724-32. PubMed ID: 17904593
    [Abstract] [Full Text] [Related]

  • 33. Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism.
    Hou L, Ju C, Zhang J, Song J, Ge Y, Yue W.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):27-31. PubMed ID: 18561913
    [Abstract] [Full Text] [Related]

  • 34. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
    Jaworska-Feil L, Jantas D, Leskiewicz M, Budziszewska B, Kubera M, Basta-Kaim A, Lipkowski AW, Lason W.
    Neuropeptides; 2010 Dec 28; 44(6):495-508. PubMed ID: 20869113
    [Abstract] [Full Text] [Related]

  • 35. Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain.
    Hamilton A, Patterson S, Porter D, Gault VA, Holscher C.
    J Neurosci Res; 2011 Apr 28; 89(4):481-9. PubMed ID: 21312223
    [Abstract] [Full Text] [Related]

  • 36. Bee venom protects SH-SY5Y human neuroblastoma cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death.
    Doo AR, Kim SN, Kim ST, Park JY, Chung SH, Choe BY, Chae Y, Lee H, Yin CS, Park HJ.
    Brain Res; 2012 Jan 06; 1429():106-15. PubMed ID: 22078207
    [Abstract] [Full Text] [Related]

  • 37. The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain.
    Parthsarathy V, Hölscher C.
    Eur J Pharmacol; 2013 Jan 30; 700(1-3):42-50. PubMed ID: 23276669
    [Abstract] [Full Text] [Related]

  • 38. Neuregulin-1 protects against neurotoxicities induced by Swedish amyloid precursor protein via the ErbB4 receptor.
    Woo RS, Lee JH, Kim HS, Baek CH, Song DY, Suh YH, Baik TK.
    Neuroscience; 2012 Jan 27; 202():413-23. PubMed ID: 22186019
    [Abstract] [Full Text] [Related]

  • 39. Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
    Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H, Jacobsen SD, Moses AC, Mølck AM, Nielsen HS, Nowak J, Solberg H, Thi TD, Zdravkovic M, Moerch U.
    Endocrinology; 2010 Apr 27; 151(4):1473-86. PubMed ID: 20203154
    [Abstract] [Full Text] [Related]

  • 40. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice.
    Xiong H, Zheng C, Wang J, Song J, Zhao G, Shen H, Deng Y.
    J Alzheimers Dis; 2013 Apr 27; 37(3):623-35. PubMed ID: 24008687
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.